- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.07. | GSK pays $500M to enter drugmaking alliance with Hengrui | ||
| 28.07. | GenAI and real-world data in pharma: 4 questions to fuel effective insights | ||
| 28.07. | Redefining commercial success in specialty lite with alternative channels | ||
| 25.07. | FDA delays approval decision for Bayer menopause therapy | ||
| 25.07. | Bristol Myers shuffles its executive ranks with new CMO | ||
| 25.07. | In reversal, European regulators take positive view on Lilly Alzheimer's drug | ||
| 25.07. | Sarepta woes mount as Duchenne gene therapy knocked back in Europe | ||
| 24.07. | A TCG offshoot pulls in $400M for biotech startup creation | ||
| 24.07. | Galapagos, having backtracked on split, weighs sale of cell therapy business | ||
| 24.07. | Rocket lays off staff; Abivax capitalizes on immune drug data | ||
| 24.07. | [Podcast] The Progress Profile: Alzheimer's Research in Focus | ||
| 24.07. | AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trial | ||
| 23.07. | RFK Jr. adopts CDC panel recommendation to remove thimerosal from flu shots | ||
| 23.07. | Roche stops shipping Sarepta gene therapy in some countries outside US | ||
| 23.07. | Abivax stock soars on trial data for ulcerative colitis drug | ||
| 23.07. | Dispatch emerges with $216M and plans for a 'universal' solid tumor therapy | ||
| 22.07. | Sanofi to acquire vaccine biotech in billion-dollar deal | ||
| 22.07. | Replimune drug rejected by FDA; Omega raises $647M biotech fund | ||
| 22.07. | FDA panel elevates concerns over antidepressant use during pregnancy | ||
| 21.07. | Former biotech executive appointed to lead FDA drug review office | ||
| 21.07. | 5 questions on Sarepta, the FDA and a Duchenne gene therapy crisis | ||
| 21.07. | Alkermes narcolepsy drug headed for late-stage testing | ||
| 21.07. | Apples to apples: Stelara biosimilars and the fight for market share | ||
| 21.07. | From bench to batch: AAV manufacturing for the next-generation of gene therapies | ||
| 18.07. | FDA to ask Sarepta to stop shipping Duchenne gene therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .